Who is conducting the trial?
Researchers at the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU), University of Southampton, the National University of Singapore (NUS), National University Health System (NUHS) and Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), Technology and Research (A*STAR) as well as at the Liggins Institute, at the University of Auckland have developed the trial in collaboration with researchers at the Nestlé Research Center.
The study is the latest trial in the partnership between the EpiGen Global Research Consortium and the Nestlé Research Center.
“We are excited to move into this next stage of our collaboration as it harnesses the knowledge generated thus far, to study a nutritional intervention aimed at improving the health of mothers and their children. The trial may also generate new information that can be used to advise women on the optimal nutrition before and during pregnancy for a healthy pregnancy outcome, and for the future health of their babies” says Thomas Beck, Head of the Nestlé Research Center.
What does the trial involve?
The study will recruit 1,800 women, before they conceive, across three centres in Southampton, Singapore and Auckland. Participants will be asked to drink the nutrients twice a day before pregnancy and to continue during pregnancy.
Chief Investigator Keith Godfrey, Professor of Epidemiology and Human Development at the MRC LEU, University of Southampton, comments: “The pre-conception phase is very important to ensure women are getting the best nutrition in preparation for their pregnancy. By starting before conception, we hope that there will be better outcomes for the mother and baby. Should significant impact on maintaining health and supporting early development be demonstrated, it could have implications for health policy and strengthen arguments for the provision of pre-conceptional nutritional advice to the general population.”